Category: Family

Coenzyme Q and neurological conditions

Coenzyme Q and neurological conditions

Ginseng health benefits, v. The conditoins of attenuation Coenztme the worsening Coenzgme the total UPDRS coonditions by coenzyme Q Joint health regeneration was also seen in each of the Flavonoids in fruits parts of the UPDRS Herbal remedies for muscle recovery [part Neurologcal A], activities of daily living [ADL] neurologicak II; Coenzyme Q and neurological conditions, and motor [part III; C], last observation carried forward. UbiB proteins regulate cellular CoQ distribution in Saccharomyces cerevisiae. In addition, new therapeutic targets were introduced for the next drug discoveries. Coenzyme Q intake elevates the mitochondrial and tissue levels of coenzyme Q and α-tocopherol in young mice. de Bustos F, Molina JA, Jimenez-Jimenz FJ, Garcia-Redondo A, Gomez-Escalonilla C, Porta-Etessam J, et al. It has been shown that CoQ 10 improves cognitive functions, regulates mitochondrial functions and facilitates the synthesis of ATP McDonald, Sohal, Forster, Coenzyme Q and neurological conditions

Coenzyme Q and neurological conditions -

Mol Aspects Med — Tang G, Rios PG, Kuo S-H, Akman HO, Rosoklija G, Tanji K et al Mitochondrial abnormalities in temporal lobe of autistic brain.

Neurobiol Dis — Tawfik MK Coenzyme Q10 enhances the anticonvulsant effect of phenytoin in pilocarpine-induced seizures in rats and ameliorates phenytoin-induced cognitive impairment and oxidative stress. Epilepsy Behav 22 4 — Teoh HL, Carey K, Sampaio H, Mowat D, Roscioli T, Farrar M Inherited paediatric motor neuron disorders: beyond spinal muscular atrophy.

Neural plasticity. Neurology 61 11 — von Büdingen H-C, Bar-Or A, Zamvil SS B cells in multiple sclerosis: connecting the dots. Curr Opin Immunol 23 6 — J Alzheimers Dis 14 2 — Neuropsychobiology 36 2 — Wilson RB, Roof DM Respiratory deficiency due to loss of mitochondrial DNA in yeast lacking the frataxin homologue.

Nat Genet 16 4 — Wingo TS, Cutler DJ, Yarab N, Kelly CM, Glass JD The heritability of amyotrophic lateral sclerosis in a clinically ascertained United States research registry.

Xanthos DN, Sandkühler J Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity. Nat Rev Neurosci 15 1 — Yamada ES, Respondek G, Müssner S, De Andrade A, Höllerhage M, Depienne C et al Annonacin, a natural lipophilic mitochondrial complex I inhibitor, increases phosphorylation of tau in the brain of FTDP transgenic mice.

Exp Neurol — Yang X, Yang Y, Li G, Wang J, Yang ES Coenzyme Q10 attenuates β-amyloid pathology in the aged transgenic mice with Alzheimer presenilin 1 mutation.

J Mol Neurosci 34 2 — J Neurochem 5 — Mol Neurobiol 54 5 — Arch Toxicol 92 4 — Zhou Y, Cao Z, Yang M, Xi X, Guo Y, Fang M et al Comorbid generalized anxiety disorder and its association with quality of life in patients with major depressive disorder.

Sci Rep 7 1 :1—8. Zucchi E, Bonetto V, Sorarù G, Martinelli I, Parchi P, Liguori R et al Neurofilaments in motor neuron disorders: towards promising diagnostic and prognostic biomarkers. Mol Neurodegener 15 1 :1— Download references. Department of Pharmacology, ISF College of Pharmacy, Moga, , Punjab, India.

Department of Pharmaceutics, ISF College of Pharmacy, Moga, , Punjab, India. Affiliated to IK Gujral Punjab Technical University, Jalandhar, , Punjab, India. You can also search for this author in PubMed Google Scholar. Nilima Pradhan wrote the manuscript, Charan Singh did the critical revision of the manuscript, and Arti Singh designed the article and did the final editing and revision of the manuscripts.

All authors read and approved the manuscript, and all data were generated in-house, and no paper mill was used. Correspondence to Arti Singh. Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Reprints and permissions. Pradhan, N. Coenzyme Q10 a mitochondrial restorer for various brain disorders. Naunyn-Schmiedeberg's Arch Pharmacol , — Download citation. Received : 18 June Accepted : 14 September Published : 01 October Issue Date : November Anyone you share the following link with will be able to read this content:.

Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative. Abstract Coenzyme Q10 ubiquinone or CoQ10 is a lipid molecule that acts as an electron mobile carrier of the electron transport chain and also contains antioxidant properties.

Access this article Log in via an institution. Availability of data and materials Not applicable. Pharmacol Biochem Behav — Article CAS PubMed Google Scholar Abuelezz SA, Hendawy N, Magdy Y Targeting oxidative stress, cytokines and serotonin interactions via indoleamine 2, 3 dioxygenase by coenzyme Q role in suppressing depressive like behavior in rats.

J Neuroimmune Pharmacol 12 2 — Article PubMed Google Scholar Ahmadi A, Haghighi AH, Nikkhah K, Askari R The effect of eight weeks combined exercise training and coenzyme Q10 supplementation on motor function in patients with multiple sclerosis.

Medical Journal of Mashhad University of Medical Sciences 61 2 — Google Scholar Al-Ghamdi M, Al-Ayadhi L, El-Ansary A Selected biomarkers as predictive tools in testing efficacy of melatonin and coenzyme Q on propionic acid-induced neurotoxicity in rodent model of autism.

BMC Neurosci 15 1 :1—10 Article CAS Google Scholar Allen J, Romay-Tallon R, Brymer KJ, Caruncho HJ, Kalynchuk LE Mitochondria and mood: mitochondrial dysfunction as a key player in the manifestation of depression.

Front Neurosci Article PubMed PubMed Central Google Scholar Andalib S, Mashhadi-Mousapour M, Bijani S, Hosseini M-J Coenzyme Q 10 alleviated behavioral dysfunction and bioenergetic function in an animal model of depression.

Neurochem Res 44 5 — Article CAS PubMed Google Scholar Andreazza AC, Shao L, Wang J-F, Young LT Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder.

Science — Article CAS PubMed Google Scholar Bădescu S, Tătaru C, Kobylinska L, Georgescu E, Zahiu D, Zăgrean A et al The association between diabetes mellitus and depression. J Med Life 9 2 PubMed PubMed Central Google Scholar Baker BM, Haynes CM Mitochondrial protein quality control during biogenesis and aging.

Trends Biochem Sci 36 5 — Article CAS PubMed Google Scholar Bakunina N, Pariante CM, Zunszain PA Immune mechanisms linked to depression via oxidative stress and neuroprogression. Immunology 3 — Article CAS PubMed PubMed Central Google Scholar Baluchnejadmojarad T, Roghani M Coenzyme q10 ameliorates neurodegeneration, mossy fiber sprouting, and oxidative stress in intrahippocampal kainate model of temporal lobe epilepsy in rat.

J Mol Neurosci 49 1 — Article CAS PubMed Google Scholar Bansal Y, Kuhad A Mitochondrial dysfunction in depression. Curr Neuropharmacol 14 6 — Article CAS PubMed PubMed Central Google Scholar Barcelos IP, Troxell RM, Graves JS Mitochondrial dysfunction and multiple sclerosis.

Biology 8 2 Article CAS Google Scholar Beal MF, Brouillet E, Jenkins BG, Ferrante RJ, Kowall NW, Miller J et al Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid.

J Neurosci 13 10 — Article CAS PubMed PubMed Central Google Scholar Beal MF, Henshaw DR, Jenkins BG, Rosen BR, Schulz JB Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate. Ann Neurol 36 6 — Article CAS PubMed Google Scholar Beal MF, Matthews RT, Tieleman A, Shults CW Coenzyme Q10 attenuates the 1-methylphenyl-1, 2, 3, 6-tetrahydropyridine MPTP induced loss of striatal dopamine and dopaminergic axons in aged mice.

Brain Res 1 — Article CAS PubMed Google Scholar Belardinelli R, Muçaj A, Lacalaprice F, Solenghi M, Seddaiu G, Principi F et al Coenzyme Q10 and exercise training in chronic heart failure. Eur Heart J 27 22 — Article CAS PubMed Google Scholar Ben-Shachar D, Zuk R, Gazawi H, Reshef A, Sheinkman A, Klein E Increased mitochondrial complex I activity in platelets of schizophrenic patients.

Int J Neuropsychopharmacol 2 4 — Article CAS PubMed Google Scholar Bergamasco B, Scarzella L, La Commare P Idebenone, a new drug in the treatment of cognitive impairment in patients with dementia of the Alzheimer type.

Funct Neurol 9 3 — CAS PubMed Google Scholar Berk M, Kapczinski F, Andreazza AC, Dean O, Giorlando F, Maes M et al Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors.

Neurosci Biobehav Rev 35 3 — Article CAS PubMed Google Scholar Bhagavan HN, Chopra RK Coenzyme Q absorption, tissue uptake, metabolism and pharmacokinetics. Free Radical Res 40 5 — Article CAS Google Scholar Bhardwaj M, Kumar A Neuroprotective mechanism of coenzyme Q10 CoQ10 against PTZ induced kindling and associated cognitive dysfunction: possible role of microglia inhibition.

Pharmacol Rep 68 6 — Article CAS PubMed Google Scholar Bhatt S, Nagappa AN, Patil CR. Am J Public Health 90 4 Article CAS PubMed PubMed Central Google Scholar Bonakdar RA, Guarneri E Coenzyme Q Ann Neurol — Article CAS PubMed Google Scholar Calabresi PA Diagnosis and management of multiple sclerosis.

Am Fam Physician 70 10 — PubMed Google Scholar Cambridge H. Neurochem Int 48 4 — Article CAS PubMed Google Scholar Cleren C, Yang L, Lorenzo B, Calingasan NY, Schomer A, Sireci A et al Therapeutic effects of coenzyme Q10 CoQ10 and reduced CoQ10 in the MPTP model of Parkinsonism.

J Neurochem 6 — Article CAS PubMed Google Scholar Constantino JN, Charman T Diagnosis of autism spectrum disorder: reconciling the syndrome, its diverse origins, and variation in expression.

Altern Med Rev 14 1 —78 Google Scholar Cordero MD, Cano-García FJ, Alcocer-Gómez E, De Miguel M, Sánchez-Alcázar JA Oxidative stress correlates with headache symptoms in fibromyalgia: coenzyme Q 10 effect on clinical improvement.

Mary Ann Liebert Inc, New Rochelle Book Google Scholar Cozzolino M, Carrì MT Mitochondrial dysfunction in ALS. Prog Neurobiol 97 2 —66 Article CAS PubMed Google Scholar Crane FL Biochemical functions of coenzyme Q J Am Coll Nutr 20 6 — Article CAS PubMed Google Scholar Cwik VA What is amyotrophic lateral sclerosis.

Amyotrophic Lateral Sclerosis: a Guide for Patients and Families —16 Google Scholar Dallner G, Sindelar PJ Regulation of ubiquinone metabolism. Free Radical Biol Med 29 3—4 — Article CAS Google Scholar De Bustos F, Jiménez-Jiménez F, Molina J, Gómez-Escalonilla C, De Andres C, Del Hoyo P et al Serum levels of coenzyme Q10 in patients with multiple sclerosis.

The Lancet Neurology 6 10 — Article PubMed CAS Google Scholar DiMauro S, Schon EA Mitochondrial respiratory-chain diseases. N Engl J Med 26 — Article CAS PubMed Google Scholar DiMauro S, Quinzii CM, Hirano M Mutations in coenzyme Q 10 biosynthetic genes. J Clin Investig 3 — Article CAS PubMed PubMed Central Google Scholar Dolatabadi HRD, Reisi P, Alaei H, Malekabadi HA, Pilehvarian AA Folic acid and coenzyme Q10 ameliorate cognitive dysfunction in the rats with intracerebroventricular injection of streptozotocin.

J Alzheimers Dis 27 1 — Article CAS PubMed PubMed Central Google Scholar Ebrahimi S, Haghighi A, Nikkhah K, Hamidi H Effects of coenzyme Q10 supplementation on antioxidant enzyme and lipid peroxide activities in women with multiple sclerosis: a randomized, placebo-controlled trial.

Epilepsy Behav 25 2 — Article PubMed PubMed Central Google Scholar Moccia M, Capacchione A, Lanzillo R, Carbone F, Saccà F, De Rosa A, et al. J Dev Orig Health Dis 7 5 — Article CAS PubMed Google Scholar Fetoni AR, Piacentini R, Fiorita A, Paludetti G, Troiani D Water-soluble coenzyme Q10 formulation Q-ter promotes outer hair cell survival in a guinea pig model of noise induced hearing loss NIHL.

Brain Res — Article CAS PubMed Google Scholar Filiano JJ, Goldenthal MJ, Harker Rhodes C, Marin-Garcia J Mitochondrial dysfunction in patients with hypotonia, epilepsy, autism, and developmental delay: HEADD syndrome.

J Child Neurol 17 6 — Article Google Scholar Folbergrová J, Kunz WS Mitochondrial dysfunction in epilepsy. Mol Cell Neurosci —81 Article PubMed CAS Google Scholar Galasko DR, Peskind E, Clark CM, Quinn JF, Ringman JM, Jicha GA et al Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures.

Arch Neurol 69 7 — Article PubMed PubMed Central Google Scholar Garrido-Maraver J, Cordero MD, Oropesa-Avila M, Vega AF, de la Mata M, Pavon AD et al Clinical applications of coenzyme Q Front Biosci landmark Ed 19 4 — Article CAS Google Scholar Gibson-Smith D, Bot M, Snijder M, Nicolaou M, Derks EM, Stronks K et al The relation between obesity and depressed mood in a multi-ethnic population.

J Neurol 3 — Article CAS PubMed Google Scholar Goebel HH, Heipertz R, Scholz W, Iqbal K, Tellez-nagel I Juvenile Huntington chorea: clinical, ultrastructural, and biochemical studies.

CNS Neurosci Ther 23 1 :5—22 Article PubMed Google Scholar Grande I, Berk M, Birmaher B, Vieta E Bipolar disorder. Ann Neurol 39 3 — Article CAS PubMed Google Scholar Gvozdjáková A, Kucharská J, Ostatníková D, Babinská K, Nakládal D, Crane FL Ubiquinol improves symptoms in children with autism.

Ann Neurol 37 6 — Article CAS PubMed Google Scholar Hart PE, Lodi R, Rajagopalan B, Bradley JL, Crilley JG, Turner C et al Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up.

Arch Neurol 62 4 — Article PubMed Google Scholar Hasler G Pathophysiology of depression: do we have any solid evidence of interest to clinicians? World Psychiatry 9 3 Article PubMed PubMed Central Google Scholar Hauser SL, Goodin DS Multiple sclerosis and other demyelinating diseases.

Harrisons Principles of Internal Medicine 16 2 Google Scholar Holper L, Ben-Shachar D, Mann JJ Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease.

Neuropsychopharmacology 44 5 — Article CAS PubMed Google Scholar Horstink MW, Van Engelen BG The effect of coenzyme Q10 therapy in Parkinson disease could be symptomatic.

Arch Neurol 60 8 — Article PubMed Google Scholar Jahangard L, Yasrebifar F, Haghighi M, Ranjbar A, Mehrpooya M Influence of adjuvant coenzyme Q10 on inflammatory and oxidative stress biomarkers in patients with bipolar disorders during the depressive episode.

Mol Biol Rep 46 5 — Article CAS PubMed Google Scholar Kaufmann P, Thompson JL, Levy G, Buchsbaum R, Shefner J, Krivickas LS et al Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III. Ann Neurol 66 2 — Article CAS PubMed PubMed Central Google Scholar Kawasaki T, Singh RB, Germaine C, Halberg F Effects of coenzyme Q10 administration in amyotrophic lateral sclerosis ALS Report of a case and review.

J Neurosci 26 19 — Article CAS PubMed PubMed Central Google Scholar Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR et al The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication NCS-R.

JAMA 23 — Article PubMed Google Scholar Khalilian B, Madadi S, Fattahi N, Abouhamzeh B Coenzyme Q10 enhances remyelination and regulate inflammation effects of cuprizone in corpus callosum of chronic model of multiple sclerosis. J Mol Histol 52 1 — Article CAS PubMed Google Scholar Khurana D, Salganicoff L, Melvin J, Hobdell E, Valencia I, Hardison H et al Epilepsy and respiratory chain defects in children with mitochondrial encephalopathies.

Neuropediatrics 39 01 :8—13 Article CAS PubMed Google Scholar Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O et al Amyotrophic lateral sclerosis. The Lancet — Article CAS Google Scholar Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S et al Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism.

Ann Neurol 41 2 — Article CAS PubMed Google Scholar Kuehner C Why is depression more common among women than among men? The Lancet Psychiatry 4 2 — Article PubMed Google Scholar Kunz WS, Kudin AP, Vielhaber S, Blümcke I, Zuschratter W, Schramm J et al Mitochondrial complex I deficiency in the epileptic focus of patients with temporal lobe epilepsy.

Ann Neurol 48 5 — Article CAS PubMed Google Scholar Langston JW, Ballard P, Tetrud JW, Irwin I Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science — Article CAS PubMed Google Scholar Lee J, Boo JH, Ryu H The failure of mitochondria leads to neurodegeneration: do mitochondria need a jump start?

Adv Drug Deliv Rev 61 14 — Article CAS PubMed PubMed Central Google Scholar Legido A, Goldenthal M, Garvin B, Damle S, Corrigan K, Connell J, et al. Nature — Article CAS PubMed Google Scholar Li G, Jack CR, Yang XF, Yang ES Diet supplement CoQ10 delays brain atrophy in aged transgenic mice with mutations in the amyloid precursor protein: an in vivo volume MRI study.

BioFactors 32 1—4 — Article CAS PubMed Google Scholar Littarru GP, Tiano L Bioenergetic and antioxidant properties of coenzyme Q recent developments. J Neurol Sci 2 — Article CAS PubMed Google Scholar Madrigal JL, Olivenza R, Moro MA, Lizasoain I, Lorenzo P, Rodrigo J et al Glutathione depletion, lipid peroxidation and mitochondrial dysfunction are induced by chronic stress in rat brain.

Neuropsychopharmacology 24 4 — Article CAS PubMed Google Scholar Mahad DJ, Ziabreva I, Campbell G, Lax N, White K, Hanson PS et al Mitochondrial changes within axons in multiple sclerosis.

Brain 5 — Article PubMed Google Scholar Malinska D, Kulawiak B, Kudin AP, Kovacs R, Huchzermeyer C, Kann O, et al. J Alzheimers Dis 10 1 —73 Article CAS PubMed Google Scholar Mancuso M, Orsucci D, Volpi L, Calsolaro V, Siciliano G Coenzyme Q10 in neuromuscular and neurodegenerative disorders.

Curr Drug Targets 11 1 — Article CAS PubMed Google Scholar Marin-Garcia J, Ananthakrishnan R, Goldenthal MJ, Filiano JJ, Sarnat HB Skeletal muscle mitochondrial defects in nonspecific neurologic disorders. Pediatr Neurol 21 2 — Article CAS PubMed Google Scholar Matthews RT, Yang L, Browne S, Baik M, Beal MF Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects.

Proc Natl Acad Sci 95 15 — Article CAS PubMed PubMed Central Google Scholar McGarry A, McDermott M, Kieburtz K, de Blieck EA, Beal F, Marder K et al A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease. Neurology 88 2 — Article CAS PubMed PubMed Central Google Scholar Menzies FM, Ince PG, Shaw PJ a Mitochondrial involvement in amyotrophic lateral sclerosis.

Neurochem Int 40 6 — Article CAS PubMed Google Scholar Menzies FM, Cookson MR, Taylor RW, Turnbull DM, Chrzanowska-Lightowlers ZM, Dong L et al b Mitochondrial dysfunction in a cell culture model of familial amyotrophic lateral sclerosis. Brain 7 — Article PubMed Google Scholar Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RM, Petukhova M et al Lifetime and month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication.

Arch Gen Psychiatry 64 5 — Article PubMed PubMed Central Google Scholar Merikangas KR, Jin R, He J-P, Kessler RC, Lee S, Sampson NA et al Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative.

Arch Gen Psychiatry 68 3 — Article PubMed PubMed Central Google Scholar Mirrione MM, Tsirka SE. Ther Adv Neurol Disord Article CAS PubMed PubMed Central Google Scholar Molina J, De Bustos F, Jiménez-Jiménez F, Gómez-Escalonilla C, García-Redondo A, Esteban J et al Serum levels of coenzyme Q 10 in patients with amyotrophic lateral sclerosis.

J Neural Transm 8—9 — Article CAS PubMed Google Scholar Molyneux SL, Florkowski CM, George PM, Pilbrow AP, Frampton CM, Lever M et al Coenzyme Q an independent predictor of mortality in chronic heart failure. J Am Coll Cardiol 52 18 — Article CAS PubMed Google Scholar Moreira PI, Santos MS, Sena C, Nunes E, Seiça R, Oliveira CR CoQ10 therapy attenuates amyloid β-peptide toxicity in brain mitochondria isolated from aged diabetic rats.

Exp Neurol 1 — Article CAS PubMed Google Scholar Mousavinejad E, Ghaffari MA, Riahi F, Hajmohammadi M, Tiznobeyk Z, Mousavinejad M Coenzyme Q10 supplementation reduces oxidative stress and decreases antioxidant enzyme activity in children with autism spectrum disorders.

J Neurosci 32 41 — Article CAS PubMed PubMed Central Google Scholar Nierenberg AA, Kansky C, Brennan BP, Shelton RC, Perlis R, Iosifescu DV Mitochondrial modulators for bipolar disorder: a pathophysiologically informed paradigm for new drug development.

Aust N Z J Psychiatry 47 1 —42 Article PubMed Google Scholar Nissenkorn A, Zeharia A, Lev D, Watemberg N, Fattal-Valevski A, Barash V et al Neurologic presentations of mitochondrial disorders. J Child Neurol 15 1 —48 Article CAS PubMed Google Scholar NN-P Investigators A randomized clinical trial of coenzyme Q10 and GPI in early Parkinson disease.

Dev Med Child Neurol 47 3 — Article CAS PubMed Google Scholar Paulsen JS, Hayden M, Stout JC, Langbehn DR, Aylward E, Ross CA et al Preparing for preventive clinical trials: the Predict-HD study. Arch Neurol 63 6 — Article PubMed Google Scholar Pearson-Smith JN, Patel M Metabolic dysfunction and oxidative stress in epilepsy.

Int J Mol Sci 18 11 Article PubMed Central CAS Google Scholar Prakash S, Sunitha J, Hans M Role of coenzyme Q10 as an antioxidant and bioenergizer in periodontal diseases. Indian J Pharmacol 42 6 Article CAS PubMed PubMed Central Google Scholar Przedborski S, Jackson-Lewis V Mechanisms of MPTP toxicity.

BioFactors 32 1—4 — Article CAS PubMed PubMed Central Google Scholar Rollins BL, Morgan L, Hjelm BE, Sequeira A, Schatzberg AF, Barchas JD et al Mitochondrial complex I deficiency in schizophrenia and bipolar disorder and medication influence. Molecular Neuropsychiatry 3 3 — CAS PubMed PubMed Central Google Scholar Ross CA, Shoulson I Huntington disease: pathogenesis, biomarkers, and approaches to experimental therapeutics.

Parkinsonism Relat Disord S—S Article PubMed Google Scholar Rossignol D, Frye R Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol Psychiatry 17 3 — Article CAS PubMed Google Scholar Rötig A, de Lonlay P, Chretien D, Foury F, Koenig M, Sidi D et al Aconitase and mitochondrial iron—sulphur protein deficiency in Friedreich ataxia.

Psychiatry Investig 14 3 Article PubMed PubMed Central Google Scholar Samsom JN, Wong AH Schizophrenia and depression co-morbidity: what we have learned from animal models. Front Psych Google Scholar Sanoobar M, Eghtesadi S, Azimi A, Khalili M, Jazayeri S, Reza GM Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with relapsing—remitting multiple sclerosis.

Int J Neurosci 11 — Article CAS PubMed Google Scholar Sanoobar M, Dehghan P, Khalili M, Azimi A, Seifar F Coenzyme Q10 as a treatment for fatigue and depression in multiple sclerosis patients: a double blind randomized clinical trial. Nutr Neurosci 19 3 — Article CAS PubMed Google Scholar Saravi SSS, Dehpour AR Potential role of organochlorine pesticides in the pathogenesis of neurodevelopmental, neurodegenerative, and neurobehavioral disorders: a review.

Life Sci — Article CAS Google Scholar Sattarinezhad E, Shafaroodi H, Sheikhnouri K, Mousavi Z, Moezi L The effects of coenzyme Q10 on seizures in mice: the involvement of nitric oxide. Epilepsy Behav —42 Article PubMed Google Scholar Schuelke M, Smeitink J, Mariman E, Loeffen J, Plecko B, Trijbels F et al Mutant NDUFV1 subunit of mitochondrial complex I causes leukodystrophy and myoclonic epilepsy.

Nat Genet 21 3 — Article CAS PubMed Google Scholar Senin U, Parnetti L, Barbagallo-Sangiorgi G, Bartorelli L, Bocola V, Capurso A et al Idebenone in senile dementia of Alzheimer type: a multicentre study. Arch Gerontol Geriatr 15 3 — Article CAS PubMed Google Scholar Shadrina M, Bondarenko EA, Slominsky PA Genetics factors in major depression disease.

Front Psych Article Google Scholar Shoffner J, Hyams L, Langley GN, Cossette S, Mylacraine L, Dale J et al Fever plus mitochondrial disease could be risk factors for autistic regression.

J Child Neurol 25 4 — Article PubMed Google Scholar Shults CW Coenzyme Q10 in neurodegenerative diseases.

Ann Neurol —4 Article CAS PubMed Google Scholar Shults CW, Beal MF, Fontaine D, Nakano K, Haas R Absorption, tolerability, and effects on mitochondrial activity of oral coenzyme Q10 in parkinsonian patients.

Neurology 50 3 — Article CAS PubMed Google Scholar Shults CW, Oakes D, Kieburtz K, Beal MF, Haas R, Plumb S et al Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline.

Attia, H. Neuroprotective effects of coenzyme Q10 on paraquat-induced Parkinson's disease in experimental animals. Baluchnejadmojarad, T.

Coenzyme q10 ameliorates neurodegeneration, mossy fiber sprouting, and oxidative stress in intrahippocampal kainate model of temporal lobe epilepsy in rat. Bartels, S. Mental health service use by elderly patients with bipolar disorder and unipolar major depression.

Psychiatry 8, — Beal, M. Bioenergetic approaches for neuroprotection in Parkinson's disease. Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q 10 as a potential treatment. Belousova, M. Neuroprotective effectiveness of intravenous ubiquinone in rat model of irreversible cerebral ischemia.

Betarbet, R. Animal models of Parkinson's disease. Bioessays 24, — Bigal, M. Age-dependent prevalence and clinical features of migraine. Neurology 67, — Bliss, T. synaptic model of memory: long-term potentiation in the hippocampus.

Nature , 31— Bonda, D. euronal failure in Alzheimer's disease: a view through the oxidative stress looking-glass. Borchelt, D. Neuron 17, — Borek, C.

Anti-aging effects of coenzyme Q Agro Food Industry Hi Tech. Google Scholar. Butterfield, D. Perspectives on oxidative stress in Alzheimer's disease and predictions of future research emphases. Alzheimers Dis. Caspi, A. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene.

Science , — Cedeno, D. Synthesis of UQ10analogs, Measurement of Their Midpoint Potentials and Their Effects on the Activity of WT and T61V bc1 Complexes From Rhodobacter sphaeroides Dissertation. Department of Chemistry and Biochemistry, The University of Arizona, Tuscon, AZ, United States.

Cenci, M. Dopamine dysregulation of movement control in L-DOPA-induced dyskinesia. Trends Neurosci. Chan, A. Supplementation with apple juice attenuates presenilin-1 overexpression during dietary and genetically-induced oxidative stress.

Chan, D. Fusion and fission: interlinked processes critical for mitochondrial health. Pathogenesis and management of the diabetogenic effect of statins: a role for adiponectin and coenzyme Q 10? Chariot, P. Choreic movements and MRI abnormalities in the subthalamic nuclei reversible after administration of coenzyme Q10 and multiple vitamins in a patient with bilateral optic neuropathy.

Chen, Q. Impairment of hippocampal long-term potentiation by Alzheimer amyloid β-peptides. Chen, R. Coenzyme Q10 treatment in mitochondrial encephalomyopathies.

Chen, S. Detection of suppressed maturation of the human COQ5 protein in the mitochondria following mitochondrial uncoupling by an antibody recognizing both precursor and mature forms of COQ5.

Mitochondrion 13, — Chen, Y. Antidiabetic drug metformin GlucophageR increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription. Cherubini, A. Antioxidant profile and early outcome in stroke patients.

Stroke 31, — Choonara, Y. Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders. Chuang, Y. Contribution of nitric oxide, superoxide anion, and peroxynitrite to activation of mitochondrial apoptotic signaling in hippocampal CA3 subfield following experimental temporal lobe status epilepticus.

Epilepsia 50, — Cleren, C. Therapeutic effects of coenzyme Q10 CoQ10 and reduced CoQ10 in the MPTP model of Parkinsonism. Colnat-Coulbois, S. Bilateral subthalamic nucleus stimulation improves balance control in Parkinson's disease.

Psychiatry 76, — Corti, O. Parkinson's disease: from causes to mechanisms. Cui, S. Water-soluble coenzyme Q10 provides better protection than lipid-soluble coenzyme Q10 in a rat model of chronic tacrolimus nephropathy.

Korean J. da Silva Fernandes, K. Functional MMP-9 polymorphisms modulate plasma MMP-9 levels in multiple sclerosis patients. Dantzer, R. From inflammation to sickness and depression: when the immune system subjugates the brain.

Demirkaya, S. Malondialdehyde, glutathione peroxidase and superoxide dismutase in peripheral blood erythrocytes of patients with acute cerebral ischemia. Dexter, D. Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease. Di Monte, D. The Environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins?

Lancet Neurol. Duff, K. Increased amyloid-β42 43 in brains of mice expressing mutant presenilin 1. Nature , Dumont, M. Coenzyme Q10 decreases amyloid pathology and improves behavior in a transgenic mouse model of Alzheimer's disease.

Emmanuele, V. Heterogeneity of coenzyme Q10 deficiency: patient study and literature review. Engelsen, J. Effect of coenzyme Q10 and ginkgo biloba on warfarin dosage in patients on long-term warfarin treatment. a randomized, double-blind, placebo-controlled cross-over trial.

Erol, B. Fernandez-Abascal, J. β-Naphthoflavone and ethanol reverse mitochondrial dysfunction in a parkinsonian model of neurodegeneration. Fernández-del-Río, L. Coenzyme Q biosynthesis: An update on the origins of the benzenoid ring and discovery of new ring precursors. Metabolites 11, Ferrante, K.

Neurology 65, — Flint Beal, M. Effects of coenzyme Q10 in Huntington's disease and early Parkinson's disease. Biofactors 18, — Forester, B. Antidepressant effects of open label treatment with coenzyme Q10 in geriatric bipolar depression. Coenzyme Q10 effects on creatine kinase activity and mood in geriatric bipolar depression.

Psychiatry Neurol. Fouad, A. Hepatoprotective effect of coenzyme Q10 in rats with acetaminophen toxicity. García-Bonilla, L. Evidence for the efficacy of statins in animal stroke models: a meta-analysis.

J Neurochem. Gargano, J. Presenting symptoms and onset-to-arrival time in patients with acute stroke and transient ischemic attack. Stroke Cerebrovasc. Gazdík, F. Biological properties of coenzyme Q10 and its effects on immunity.

Geromel, V. Coenzyme Q 10 depletion is comparatively less detrimental to human cultured skin fibroblasts than respiratory chain complex deficiencies.

Free Radic. Gille, L. Ubiquinone and tocopherol: dissimilar siblings. Golde, T. Biochemical detection of Aβ isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease.

Acta Mol. Basis Dis. Groneberg, D. Coenzyme Q10 affects expression of genes involved in cell signalling, metabolism and transport in human CaCo-2 cells. Cell Biol. Guaras, A. Cell Rep. Gunes, H. Epilepsy Res. Guo, J. Effects of milk and coenzyme Q10 on the interference of acrylonitrile on vascular endothelial functions.

Zhonghua Yi Xue Za Zhi 91, — Gupta, S. Correlation of antioxidants with lipid peroxidation and lipid profile in patients suffering from coronary artery disease. Targets 13, — Gutzmann, H. Sustained Efficacy and Safety of Idebenone in the Treatment of Alzheimer's Disease: Update on a 2-year Double-Blind Multicentre Study.

Neural Transm. Vienna: Springer , 54, — Gvozdjáková, A. Harding, A. Pedigree analysis in Leber hereditary optic neuropathy families with a pathogenic mtDNA mutation. Hargreaves, I. Coenzyme Q10 in mitochondrial and lysosomal disorders.

Hathcock, J. Risk assessment for coenzyme Q10 Ubiquinone. Hauser, W. Prevalence of epilepsy in Rochester, Minnesota: — Epilepsia 32, — Hidalgo-Gutiérrez, A. Metabolic targets of coenzyme Q10 in mitochondria. Antioxidants 10, Huang, L. Clinical trials of new drugs for Alzheimer disease.

Ibrahim Fouad, G. Combination of omega 3 and coenzyme Q10 exerts neuroprotective potential against hypercholesterolemia-induced Alzheimer's-Like disease in rats. Ishrat, T. Coenzyme Q10 modulates cognitive impairment against intracerebroventricular injection of streptozotocin in rats. Jiang, T.

Oxidative stress: a major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson's disease and Alzheimer's disease. Jiménez-Jiménez, F. Coenzyme Q10 and Parkinsonian syndromes: a systematic review. Coenzyme Q10 and dementia: a systematic review. Antioxidants 12, Jing, L.

Coenzyme Q10 protects astrocytes from ROS-induced damage through inhibition of mitochondria-mediated cell death pathway. Jokeit, H. Neuropsychological aspects of type of epilepsy and etiological factors in adults.

Epilepsy Behav. Judd, L. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder.

Psychiatry 60, — The long-term natural history of the weekly symptomatic status of bipolar I disorder. Psychiatry 59, — Kadian, M. The impact of coenzyme Q10 on neurodegeneration: a comprehensive review.

Kalenikova, E. Tissue-level dynamics and redox state of Coenzyme Q10 in rats after intravenous injection of Ubiquinol. Kalin, N. Management of the depressive component of bipolar disorder. Anxiety 4, — Kalman, B. The involvement of mitochondria in the pathogenesis of multiple sclerosis.

Kemmerer, Z. UbiB proteins regulate cellular CoQ distribution in Saccharomyces cerevisiae. Kernan, W. Stroke 45, — Khalilian, B. Coenzyme Q10 enhances remyelination and regulate inflammation effects of cuprizone in corpus callosum of chronic model of multiple sclerosis.

Kidd, P. Koller, W. Neuroprotection in Parkinson's disease: an elusive goal. Komaki, H. Investigation of protective effects of coenzyme Q10 on impaired synaptic plasticity in a male rat model of Alzheimer's disease.

Kones, R. Mitochondrial therapy for Parkinson's disease: neuroprotective pharmaconutrition may be disease-modifying. Konradi, C. Molecular evidence for mitochondrial dysfunction in bipolar disorder. Psychiatry 61, — Kowalska, A. The beta-amyloid cascade hypothesis: a sequence of events leading to neurodegeneration in Alzheimer's disease.

Kumar, N. Neuroprotective effect of hesperidin and its combination with coenzyme Q10 on an animal model of ketamine-induced psychosis: behavioral changes, mitochondrial dysfunctions, and oxidative stress. Kuo, H. Coenzyme Q10 treatment in Leber's hereditary optic neuropathy.

Neuroophthalmology 25, — Kwon, K. Associations of cognitive dysfunction with motor and non-motor symptoms in patients with de novo Parkinson's disease. Lagier-Tourenne, C.

ADCK3, an ancestral kinase, is mutated in a form of recessive ataxia associated with coenzyme Q10 deficiency. Laredj, L. The molecular genetics of coenzyme Q biosynthesis in health and disease. Larochelle, C. How do immune cells overcome the blood—brain barrier in multiple sclerosis?

FEBS Lett. Lee, B. Effects of coenzyme Q10 supplementation on inflammatory markers high-sensitivity C-reactive protein, interleukin-6, and homocysteine in patients with coronary artery disease. Nutrition 28, — The relationship between coenzyme Q10, oxidative stress, and antioxidant enzymes activities and coronary artery disease.

World J. Lee, D. Mechanisms of oxidative damage in multiple sclerosis and neurodegenerative diseases: therapeutic modulation via fumaric acid esters. Leonard, B. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression.

Lessell, S. Bilateral optic neuropathy with remission in young men: variation on a theme by Leber? Lesser, G. A randomized double-blind, placebo-controlled study of oral coenzyme Q10 to relieve self-reported treatment related fatigue in newly diagnosed patients with breast cancer.

Li, H. Water-soluble coenzyme q10 inhibits nuclear translocation of apoptosis inducing factor and cell death caused by mitochondrial complex I inhibition. Water-soluble coenzyme Q10 reduces rotenone-induced mitochondrial fission.

Littarru, G. Clinical aspects of coenzyme Q an update. Nutrition 26, — Lodish, H. Longa, E. Reversible middle cerebral artery occlusion without craniectomy in rats.

Löscher, W. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. New horizons in the development of antiepileptic drugs: Innovative strategies.

Losón, O. Fis1, Mff, MiD49, and MiD51 mediate Drp1 recruitment in mitochondrial fission. Lucca, G. Increased oxidative stress in submitochondrial particles into the brain of rats submitted to the chronic mild stress paradigm.

Effects of chronic mild stress on the oxidative parameters in the rat brain. Lundblad, M. Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease.

Mabuchi, H. Effects of CoQ10 supplementation on plasma lipoprotein lipid, CoQ10 and liver and muscle enzyme levels in hypercholesterolemic patients treated with atorvastatin: a randomized double-blind study.

Atherosclerosis , e—e9. Maes, M. Psychiatry 35, — Lower plasma Coenzyme Q 10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness. Mancuso, M. Coenzyme Q10 in neuromuscular and neurodegenerative disorders.

Drug Targets 11, — Manzar, H. Cellular consequences of coenzyme Q10 deficiency in neurodegeneration of the retina and brain. Markesbery, W. Oxidative stress hypothesis in Alzheimer's disease. Matthews, R. Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects.

McCarthy, S. Paraquat induces oxidative stress and neuronal cell death; neuroprotection by water-soluble Coenzyme Q Mcdonald, S. Concurrent administration of coenzyme Q10 and α-tocopherol improves learning in aged mice.

McGarry, A. A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease. Neurology 88, — Mehrpooya, M. Evaluating the effect of coenzyme Q10 augmentation on treatment of bipolar depression: a double-blind controlled clinical trial.

Mignot, C. Phenotypic variability in ARCA2 and identification of a core ataxic phenotype with slow progression. Rare Dis. Milanlioglu, A. Serum antioxidant enzymes activities and oxidative stress levels in patients with acute ischemic stroke: influence on neurological status and outcome.

Miller, A. Mohamed, H. Mollet, J. CABC1 gene mutations cause ubiquinone deficiency with cerebellar ataxia and seizures. Moreira, P. Mitochondria: a therapeutic target in neurodegeneration. Morris, G. Coenzyme Q10 depletion in medical and neuropsychiatric disorders: potential repercussions and therapeutic implications.

Mugoni, V. Ubiad1 is an antioxidant enzyme that regulates eNOS activity by CoQ10 synthesis. Cell , — Muthukumaran, K. Ubisol-Q 10 a nanomicellar water-soluble formulation of CoQ 10 treatment inhibits Alzheimer-type behavioral and pathological symptoms in a double transgenic mouse TgAPEswe, PSEN1dE9 model of Alzheimer's disease.

Genetic susceptibility model of parkinson's disease resulting from exposure of DJ-1 deficient mice to MPTP: evaluation of neuroprotection by Ubisol-Q Parkinsons Dis. Nakazawa, H. Coenzyme Q10 protects against burn-induced mitochondrial dysfunction and impaired insulin signaling in mouse skeletal muscle.

gov website. Share sensitive information only on official, secure websites. Primary coenzyme Q10 deficiency is a disorder that can affect many parts of the body, especially the brain, muscles, and kidneys.

As its name suggests, the disorder involves a shortage deficiency of a substance called coenzyme Q The severity, combination of signs and symptoms, and age of onset of primary coenzyme Q10 deficiency vary widely.

In the most severe cases, the condition becomes apparent in infancy and causes severe brain dysfunction combined with muscle weakness encephalomyopathy and the failure of other body systems.

These problems can be life-threatening. The mildest cases of primary coenzyme Q10 deficiency can begin as late as a person's sixties and often cause cerebellar ataxia , which refers to problems with coordination and balance due to defects in the part of the brain that is involved in coordinating movement cerebellum.

Other neurological abnormalities that can occur in primary coenzyme Q10 deficiency include seizures, intellectual disability, poor muscle tone hypotonia , involuntary muscle contractions dystonia , progressive muscle stiffness spasticity , abnormal eye movements nystagmus , vision loss caused by degeneration atrophy of the optic nerves or breakdown of the light-sensing tissue at the back of the eyes retinopathy , and sensorineural hearing loss which is caused by abnormalities in the inner ear.

The neurological problems gradually get worse unless treated with coenzyme Q10 supplementation. A type of kidney dysfunction called nephrotic syndrome is another common feature of primary coenzyme Q10 deficiency. It can occur with or without neurological abnormalities.

Nephrotic syndrome occurs when damage to the kidneys impairs their function, which allows protein from the blood to pass into the urine proteinuria.

Other signs and symptoms of nephrotic syndrome include increased cholesterol in the blood hypercholesterolemia , an abnormal buildup of fluid in the abdominal cavity ascites , and swelling edema. Affected individuals may also have blood in the urine hematuria , which can lead to a reduced number of red blood cells in the body anemia , abnormal blood clotting, or reduced amounts of certain white blood cells.

Low white blood cell counts can lead to a weakened immune system and frequent infections in people with nephrotic syndrome. If not treated with coenzyme Q10 supplementation, affected individuals eventually develop irreversible kidney failure end-stage renal disease.

A type of heart disease that enlarges and weakens the heart muscle hypertrophic cardiomyopathy can also occur in primary coenzyme Q10 deficiency. The prevalence of primary coenzyme Q10 deficiency is thought to be less than 1 in , people.

Primary coenzyme Q10 deficiency is caused by mutations in genes that provide instructions for making proteins involved in the production synthesis of a molecule called coenzyme Q Collectively, they are called the COQ genes.

Most of the identified mutations have occurred in the COQ2 , COQ4 , COQ6 , COQ8A , and COQ8B genes. Smaller numbers of mutations in other COQ genes have also been found to cause primary coenzyme Q10 deficiency.

The coenzyme Q10 molecule has several critical functions in cells throughout the body. In cell structures called mitochondria , coenzyme Q10 plays an essential role in a process called oxidative phosphorylation , which converts the energy from food into a form cells can use.

Coenzyme Q10 is also involved in producing pyrimidines, which are building blocks of DNA, its chemical cousin RNA, and molecules such as ATP and GTP that serve as energy sources in the cell.

In cell membranes, coenzyme Q10 acts as an antioxidant, protecting cells from damage caused by unstable oxygen-containing molecules free radicals , which are byproducts of energy production.

Editor-in-Chief: Natural detoxification and cleanse supplements Spina Coenzme of Clinical and Experimental Medicine University of Messina Policlinico Coenzyme Q and neurological conditions Neurologiczl Consolare Cobditions Messina Coenzyme Q and neurological conditions. ISSN Print : ISSN Online : DOI: Coenzyme Q10 Coenzme is critical for the cell power supply in mitochondria. CoQ10 shuttles electrons from complexes I and II to complex III, and can be anti-oxdiative. Neurons require high energy for synaptic transmission and therefore the mitochondria dysfunction often leads to severe neuronal degeneration, as observed in many neurological disorders. Here we discuss a large number of preclinical and clinical trials for CoQ10 to elucidate the mechanisms underlying CoQ10 therapy. Official websites Coenzyme Q and neurological conditions. gov A. gov annd belongs to an official government organization in the United Flavonoids in fruits. neurolkgical website. Share sensitive information only on official, secure websites. Primary coenzyme Q10 deficiency is a disorder that can affect many parts of the body, especially the brain, muscles, and kidneys. As its name suggests, the disorder involves a shortage deficiency of a substance called coenzyme Q

Author: Zoloramar

3 thoughts on “Coenzyme Q and neurological conditions

  1. Ich denke, dass Sie sich irren. Geben Sie wir werden besprechen. Schreiben Sie mir in PM, wir werden reden.

Leave a comment

Yours email will be published. Important fields a marked *

Design by ThemesDNA.com